Back to search

Article

Molecular residual disease detection by serial tumour-informed circulating tumour DNA analysis in resectable oesophageal & gastroesophageal junctional adenocarcinoma: a prospective UK multi-centre study

2026-07-09

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The value and optimal timing of circulating tumour DNA (ctDNA) analysis in locally advanced oesophageal adenocarcinoma (OAC) is uncertain. We hypothesised that perioperative detection would predict event-free (EFS) and overall (OS) survival, and that 3-6 months post-operative detection would predict recurrence. <h4>Methods</h4> In this prospective multi-centre cohort study,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fb3fe607-91f5-5d2a-97a8-c53170b16f7c
DOI
10.64898/2026.07.06.26357371
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular residual disease detection by serial tumour-informed circulating tumour DNA analysis in resectable oesophageal & gastroesophageal junctional adenocarcinoma: a prospective UK multi-centre studyDOI 10.64898/2026.07.06.26357371
Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: the PLAGAST prospective biomarker studySemantic proximity
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal CancerSemantic proximity
Risk stratification by minimal residual disease detection and ctDNA dynamics from personalised assays in stage II-III colorectal cancer in a UK multi-centre prospective study (TRACC Part B)Semantic proximity
ctDNA as A Biomarker of Progression in Oesophageal AdenocarcinomaSemantic proximity
Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases.Semantic proximity
Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancersSemantic proximity
Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study.Semantic proximity
Tumour informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post-treatmentSemantic proximity
Prognostic potential of circulating tumor DNA detection at different time periods in resectable non-small cell lung cancer: Evidence from a meta-analysis.Semantic proximity
Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases.Semantic proximity
Analysis of the clinical value of postoperative circulating tumor DNA (ctDNA) within the first month for resected colorectal cancer in a real-world.Semantic proximity
ctDNA as a biomarker of progression in oesophageal adenocarcinoma.Semantic proximity
Select a neighboring publication to make it the new centre.